WE ARE ENDECE
ENDECE, LLC is a privately held biopharmaceutical company at the forefront of new drug discovery and development. Our library of proprietary compounds, invented and owned by ENDECE, was designed to stop disease by up-regulating specific biological pathways to stimulate a specific biological response. We focus on diseases whose treatment options are limited or non-existent and whose causes may not be well understood including multiple sclerosis (MS), osmotic demyelination syndrome (ODS), and Alzheimer’s disease.
ENDECE was founded in 2006 and is located in Mequon, Wisconsin and San Francisco, California.
ENDECE, LLC announced that it is opening an office in San Francisco, establishing a West Coast presence that reinforces its commitment to advancing its pipeline of novel therapeutics for multiple sclerosis (MS), osmotic demyelination syndrome (ODS) and other neurodegenerative diseases.read more
ENDECE will attend the 35th annual J.P. Morgan Healthcare Conference from January 9-12, 2017 in San Francisco, California. During the meeting, ENDECE will present an update on the clinical development of its lead compound, NDC-1308read more